Cipla Expands U.S. Respiratory Portfolio with Approval of Nintedanib Capsules (100mg & 150mg) for Idiopathic Pulmonary Fibrosis
You have permission to edit this article.
Source: Daily Sun April 03, 2026 13:01 UTC
Loading...
Loading...